Matthew Gall
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew Gall
Matthew Gall is recorded as CFO at Tango Therapeutics, Inc. (TNGX). Tango Therapeutics, Inc. reported in an 8-K filed April 15, 2026 that Matthew Gall was appointed Chief Financial Officer, effective April 15, 2026.
“On April 10, 2026, the Board appointed Matthew Gall, MBA, 49, as the Company’s Chief Financial Officer and principal financial officer effective as of April 15, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Malte Peters, M.D. CEO
- Barbara Weber Chairman
- Barbara Weber, M.D. Chairman
- Douglas Barry General Counsel
- Jessica Newcomb Chief Accounting Officer
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
- Lesley Calhoun Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.